CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving cancer treatment by enhancing the delivery of drug-loaded nanoparticles to tumor cells. It utilizes molecular modeling to understand how ultrasound exposure affects the transport of these nanoparticles through the tumor's extracellular matrix, aiming to create a predictive model for pe…
Cancer is the second most important cause of death in Europe, with an estimated 2.27 million new cases and 1.3 million deaths in 2020.
The prerequisite for a successful medicinal therapy is that the drug reaches its target and that toxicity towards healthy tissue is limited, however the systemic injection of drugs leads to less than 1 % of the drugs accumulating in solid tumours.
Relying on the permeability of the blood vessel in cancer tumours, the encapsulation of drugs in nanoparticles (NPs)…
NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Stuttgart
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
